Globe Life (GL)

• Market cap: $10.3B
• 1 day: -1.35%
• 5 days: -0.73%
• 1 month: 2.54%
• 3 months: 12.48%
• 6 months: 25.69%
• Year to date: 9.22%
• 1 year: -3.16%
• 5 years: 11.30%
• 10 years: 128.16%
• Sector: Financials
• Industry: Life Insurance

About: Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

Employees: 3,636

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

89% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 47

9% more capital invested

Capital invested by funds: $7.14B [Q3] → $7.76B (+$612M) [Q4]

7.38% more ownership

Funds ownership: 75.48% [Q3] → 82.86% (+7.38%) [Q4]

5% more funds holding

Funds holding: 518 [Q3] → 544 (+26) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 5 [Q3] → 5 (+0) [Q4]

14% less repeat investments, than reductions

Existing positions increased: 167 | Existing positions reduced: 194

16% less call options, than puts

Call options by funds: $91.1M | Put options by funds: $108M

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $114 7% downside
• Avg. target: $130 6% upside
• High target: $145 18% upside

6 analyst ratings

• positive: 3 50%
• neutral: 3 50%
• negative: 0 0%

Wells Fargo Elyse Greenspan 68% 1-year accuracy 77 / 114 met price target	15% upside $141	Overweight Maintained	19 Feb 2025
Keefe, Bruyette & Woods Ryan Krueger 86% 1-year accuracy 18 / 21 met price target	18% upside $145	Outperform Maintained	12 Feb 2025
Morgan Stanley Nigel Dally 100% 1-year accuracy 9 / 9 met price target	2% upside $125	Equal-Weight Maintained	11 Feb 2025
BMO Capital Jack Matten 75% 1-year accuracy 3 / 4 met price target	7% downside $114	Market Perform Initiated	23 Jan 2025
Evercore ISI Group Thomas Gallagher 80% 1-year accuracy 12 / 15 met price target	17% upside $143	Outperform Upgraded	8 Jan 2025